Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

Stockholders’ Equity (Details Narrative) - USD ($)							3 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Mar. 05, 2024	Feb. 05, 2024	Jan. 30, 2024	Jan. 25, 2024	Jan. 22, 2024	Feb. 14, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Apr. 17, 2023
Class of Stock [Line Items]
Preferred stock, shares issued							0		0
Preferred stock, shares outstanding							0		0
Stock withheld for income taxes	1,377				2,373
Net proceeds			$ 6,300,000				$ 6,282,430	$ 6,352,077
Common Stock [Member]
Class of Stock [Line Items]
Shares issued							1,555,555	421,611
Purchase Agreement [Member]
Class of Stock [Line Items]
Shares issued			476,000
Gross proceeds from issuance of common stock			$ 7,000,000.0
Net proceeds			$ 6,300,000
Purchase Agreement [Member] \| Lincoln Park Capital Fund LLC [Member]
Class of Stock [Line Items]
Shares issued								2,500
Share price								$ 21.60
Gross proceeds from issuance of common stock								$ 54,000
Purchase Agreement [Member] \| Placement Agent [Member]
Class of Stock [Line Items]
Warrant exercise price			$ 5.625
Warrants to purchase shares			62,222
Warrant expire date			Feb. 01, 2027
Purchase Agreement [Member] \| Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase common stock, shares			1,555,555				1,617,777
Warrant exercise price			$ 4.50
Warrant term			5 years
Purchase Agreement [Member] \| Pre-Funded Warrants [Member]
Class of Stock [Line Items]
Warrants to purchase common stock, shares			1,079,555
Warrant exercise price			$ 0.0001
Share price			$ 4.4999
Warrant exercised			1,079,555
Sales Agreement [Member]
Class of Stock [Line Items]
Shares issued								28,483
Share price								$ 24.40
Gross proceeds from issuance of common stock								$ 693,000
Net proceeds								$ 672,000
Securities Purchase Agreement [Member] \| Registered Direct Offering [Member] \| Accredited Investor [Member]
Class of Stock [Line Items]
Shares issued						390,628
Share price						$ 16.00
Gross proceeds from issuance of common stock						$ 6,300,000
Net proceeds						$ 5,600,000
Securities Purchase Agreement [Member] \| Registered Direct Offering [Member] \| Placement Agent [Member]
Class of Stock [Line Items]
Cash fee percentage						8.00%
Reimbursement fees						$ 60,000
Consulting Agreement [Member] \| Spartan Capital Securites LLC [Member]
Class of Stock [Line Items]
Warrants to purchase common stock, shares								158,007		158,007
Warrant exercise price										$ 20.40
Five Executive Officers and One Employee [Member]
Class of Stock [Line Items]
Shares issued					6,203
Elion Oncology [Member]
Class of Stock [Line Items]
Shares issued				5,000
Consultant [Member]
Class of Stock [Line Items]
Shares issued		1,250
Former Employee [Member]
Class of Stock [Line Items]
Shares issued	3,223